Beyond the Monolithic Gene
What ASHG has to say about gene transcripts, transcript isoforms, protein isoforms, and proteoforms, along with the research tools to come
A Pair of Diamonds
At the Quantum World Congress, Element Six shows me two diamonds, one that builds a business, another that measures biology Dr. Matthew Markham is a principal scientist at a company called Element Six. At the Quantum World Congress, held September 23 to 25, 2026 at The Hotel at the University
A Newcomer’s Map of Quantum
At the recent BioHealth Capital Region Forum, just before a panel on quantum technology, host Rich Bendis asked the audience who was not familiar with IonQ. I was one of a handful of people who raised a hand. The last time I looked into quantum computing as a field was
Software Agents have Changed Science
At Bio-IT World 2026, a Genentech scientist showed 4,000 lines of R code with no handwritten lines, and the bottleneck moved to verification.
Making Connectomics Mainstream
Neural connectomics is a tantalizing omic layer The opening statement at a Bio-IT World 2026 plenary session was bold: “Frontier AI has consumed all the text on the internet. It’s running out of biological ground truth. The most consequential missing dataset is the wiring diagram of the brain,
The Limiting Reagent
At Bio-IT World 2026 (Boston MA) the presenter Dan Rozelle from Rancho Biosciences gave a talk titled “Agents in the Loop: High Fidelity Omics Data requires Subject Matter Expertise”. Now this is the kind of talk that is catnip to me: I look forward to a talk about “omics
“We are Here” - AI and Drug Discovery by Jeremy Jenkins, Novartis’ Head of US Discovery Sciences
A field note from Dr. Jeremy Jenkins's BioIT World 2026 plenary on where AI and drug discovery actually stand today. Not the hyped version, not a future projection. The current state of AI implementation, from inside Novartis.